Pharmaceuticals
US slaps sanctions on 6 Indian companies over imports from Iran
By Unnikrishnan | 03 Aug 2025
The United States on Wednesday imposed sanctions on six Indian companies, including Alchemical Solutions, Global Industrial Chemicals, Jupiter Dye Chem, Ramniklal S Gosalia & Co
Glenmark Pharma Hits Record High on Landmark AbbVie Licensing Deal
By Cygnus | 11 Jul 2025
Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a significant licensing agreement with U.S. drugmaker AbbVie.
Sanofi to acquire Blueprint Medicines in $9.5 billion deal to bolster immunology push
By Cygnus | 02 Jun 2025
French pharmaceutical giant Sanofi is set to acquire U.S.-based Blueprint Medicines Corporation in a deal worth up to $9.5 billion
AstraZeneca acquires EsoBiotec in $1 bn deal
18 Mar 2025
British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction
Sun Pharma to acquire oncology therapy company Checkpoint in US
11 Mar 2025
Sun Pharmaceutical Industries Ltd has entered into an agreement to acquire US-based immunotherapy and targeted oncology company, Checkpoint Therapeutics Inc
CSIR develops antibiotic for drug-resistant bacteria, indigenous formula for Paracetamol
08 Jan 2025
Council of Scientific and Industrial Research (CSIR) has reported important breakthroughs, which include development of an anti-biotic to fight drug-resistant bacteria
Govt sets goal higher for India’s nutraceutical industry
08 Nov 2024
India is set to play a major role in the global nutraceutical industry, with its wealth of traditional knowledge, its Ayurveda system and policy support, as per government projections.
Customs duty exemption, GST rate cut to bring down retail prices of cancer drugs
30 Oct 2024
The maximum retail prices (MRP) of three main drugs used in the treatment of cancer, viz, Trastuzumab, Osimertinib and Durvalumab
Drug regulator finds samples of calcium supplement Shelcal 500 and antacid Pan D as spurious
27 Oct 2024
A routine inspection by the Central Drug Regulatory Authority of retail medical shops in select locations of Odisha
.webp)
Merck pays $30 million upfront to acquire cancer therapy developer Modifi Biosciences
24 Oct 2024
US pharma multinational Merck has acquired Modifi Biosciences, a developer of new oncology drug molecules, for $30 million upfront and up to $1.3 billion
